AcuityMD today announced $45 million in new funding to expand its commercial intelligence platform and advance the company's mission of accelerating adoption of cutting-edge medical technology (MedTech). The Series B round was led by ICONIQ Growth, with additional participation from Boston-based Atreides Management and New York-based Stepstone Group as well as existing investors Redpoint Ventures, Benchmark Capital, and Artisanal Ventures. To date, AcuityMD has raised more than $83 million and achieved a significant 10x increase in annual recurring revenue since its 2022 Series A raise.

AirMDR is at the cutting edge of autonomous MDR (Managed Detection and Response), enhancing cybersecurity with its AI-driven virtual analysts. This innovative technology handles 80-90% of the functions typically performed by human analysts, including triage, investigation, and response. By employing sophisticated natural language models, AirMDR provides reliable, enterprise-grade cybersecurity solutions that are affordable for small and medium-sized businesses.